A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019

Shabani, M; Ehdaei, BS; Fathi, F; Dowran, R

Dowran, R (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran.

NEW MICROBES AND NEW INFECTIONS, 2021; 42 ():

Abstract

Sofosbuvir and daclatasvir have been used successfully since 2013 for hepatitis C treatment. It has been shown by different studies that sofosbuvir ca......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索